Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3 Hepatitis C Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00641654
What this trial is testing

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis C
Göteborg University 75
Large-scale testing (Phase 3)Study completedNCT00538811
What this trial is testing

Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders

Who this might be right for
Hepatitis CGenotype 3Non-responders+1 more
Aga Khan University 40
Large-scale testing (Phase 3)Study completedNCT02442271
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 222
Testing effectiveness (Phase 2)Study completedNCT00561015
What this trial is testing

A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec BVBA 52
Large-scale testing (Phase 3)Study completedNCT02692703
What this trial is testing

Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)

Who this might be right for
Chronic Hepatitis CHCVHepatitis C Virus
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT00302081
What this trial is testing

Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 696
Post-approval studies (Phase 4)UnknownNCT00611819
What this trial is testing

Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Who this might be right for
Chronic Hepatitis CCo-Infection HIV-HCV
University of Valencia 59
Large-scale testing (Phase 3)Study completedNCT01585584
What this trial is testing

Triple-Therapy in Patients With HCV Genotype 3 Who Previously Failed Treatment

Who this might be right for
Hepatitis C
University of Calgary 11
Post-approval studies (Phase 4)Study completedNCT00143000
What this trial is testing

Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3

Who this might be right for
Hepatitis C Virus
NORDynamIC Study Group 392
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Post-approval studies (Phase 4)Study completedNCT00830609
What this trial is testing

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3

Who this might be right for
Chronic Hepatitis C
Dr. Conrado Fernandez 101
Testing effectiveness (Phase 2)Study completedNCT02133131
What this trial is testing

Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 143
Large-scale testing (Phase 3)Study completedNCT02114177
What this trial is testing

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Janssen Infectious Diseases BVBA 310
Large-scale testing (Phase 3)Study completedNCT04382937
What this trial is testing

Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
PharmaEssentia 222
Not applicableActive Not RecruitingNCT07316842
What this trial is testing

SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

Who this might be right for
Viral Hepatitis C
Center of target therapy 30
Large-scale testing (Phase 3)Study completedNCT02640157
What this trial is testing

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusGenotype 3 Hepatitis C Virus
AbbVie 506
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Study completedNCT02201953
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 558
Not applicableStudy completedNCT03303599
What this trial is testing

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6

Who this might be right for
Hepatitis C
AbbVie 2,118
Testing effectiveness (Phase 2)Study completedNCT02094443
What this trial is testing

Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

Who this might be right for
Hepatitis CLiver Disease
Debiopharm International SA 52
Next Page